Results 11 to 20 of about 32,014 (250)

Mucosal Melanoma [PDF]

open access: yesJournal of Oral Diagnosis, 2020
Primary oral mucosal melanoma (POMM) is a rare neoplasm derived from melanocytes, with unknown aetiology, and different presentation than cutaneous melanoma. It mostly affects the palate and maxillary alveolar ridge, with aspects that may mimic different lesions.
Carla Isabelly Rodrigues-Fernandes   +4 more
openaire   +2 more sources

Time-varying pattern of recurrence risk for localized melanoma in China

open access: yesWorld Journal of Surgical Oncology, 2020
Background Acral and mucosal melanomas are rarely seen in Caucasians but common in China. There are limited data on the recurrence characteristics for these patients.
Xizhi Wen   +9 more
doaj   +1 more source

Concurrent Mucosal Melanoma and Angiofibroma of the Nose [PDF]

open access: yesClinical and Experimental Otorhinolaryngology, 2016
Malignant melanoma rarely develops in the paranasal sinuses, and generally has a poor prognosis. However, mucosal melanoma can masquerade both clinically and histopathologically as a benign lesion, rendering accurate early diagnosis difficult.
Jae Hyung Hwang   +3 more
doaj   +1 more source

Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy

open access: yesScientific Reports, 2022
Limited studies have interrogated the genomic landscape of Chinese melanoma in which acral and mucosal melanoma are the mainstay. In this study, we carried out a retrospective analysis on 81 Chinese melanoma patients (15 acral, 25 mucosal and 41 ...
Fuxue Huang   +9 more
doaj   +1 more source

Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy

open access: yesCase Reports in Oncology, 2020
Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for ...
Taku Fujimura   +7 more
doaj   +1 more source

Advances in the Application of Nanomaterials to the Treatment of Melanoma

open access: yesPharmaceutics, 2022
Melanoma can be divided into cutaneous melanoma, uveal melanoma, mucosal melanoma, etc. It is a very aggressive tumor that is prone to metastasis. Patients with metastatic melanoma have a poor prognosis and shorter survival.
Zeqi Wang   +4 more
doaj   +1 more source

Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line

open access: yesCancer Communications, 2022
Background Mucosal melanoma has characteristically distinct genetic features and typically poor prognosis. The lack of representative mucosal melanoma models, especially cell lines, has hindered translational research on this melanoma subtype.
Chaoji Shi   +15 more
doaj   +1 more source

Primary malignant mucosal melanoma of the larynx: A case report and literature review

open access: yesJournal of Pathology of Nepal, 2015
Malignant mucosal melanoma is very rare entity. It comprises about 1% of all malignant melanoma and exhibit more aggressive behaviour than that of skin melanomas.
S Shrestha Khadka, MC Lee, AB Karki
doaj   +1 more source

Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy

open access: yesJournal of Translational Medicine, 2019
Background Melanoma is one of the most aggressive cancers with extremely poor prognosis, and the median survival time for stage IV patients is approximately 6 to 8 months.
Longwen Xu   +6 more
doaj   +1 more source

Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report

open access: yesFrontiers in Oncology, 2020
Background: Mucosal melanomas including melanomas of the urogenital tract represent a rare type of melanoma characterized by low mutational burden and poor prognosis.
Anne Fröhlich   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy